This report contains market size and forecasts of Acute Ischemic Stroke Diagnosis and Treatment in Global, including the following market information:
Global Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Acute Ischemic Stroke Diagnosis and Treatment market was valued at 1080.2 million in 2020 and is projected to reach US$ 1225.3 million by 2027, at a CAGR of 3.2% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Acute Ischemic Stroke Diagnosis and Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Acute Ischemic Stroke Diagnosis and Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Acute Ischemic Stroke Diagnosis and Treatment Market Segment Percentages, By Type, 2020 (%)
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Carotid Ultrasound
Cerebral Angiography
Electrocardiography
Echocardiography
Others
China Acute Ischemic Stroke Diagnosis and Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Acute Ischemic Stroke Diagnosis and Treatment Market Segment Percentages, By Application, 2020 (%)
Hospital
Specialty Clinic
Others
Global Acute Ischemic Stroke Diagnosis and Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Acute Ischemic Stroke Diagnosis and Treatment Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Acute Ischemic Stroke Diagnosis and Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Acute Ischemic Stroke Diagnosis and Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Abbott
Medtronic
Boston Scientific
Cordis
Philips
GE Healthcare
Siemens
Stryker
Genentech
Merck
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Acute Ischemic Stroke Diagnosis and Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Acute Ischemic Stroke Diagnosis and Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Acute Ischemic Stroke Diagnosis and Treatment Overall Market Size
2.1 Global Acute Ischemic Stroke Diagnosis and Treatment Market Size: 2021 VS 2027
2.2 Global Acute Ischemic Stroke Diagnosis and Treatment Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Acute Ischemic Stroke Diagnosis and Treatment Players in Global Market
3.2 Top Global Acute Ischemic Stroke Diagnosis and Treatment Companies Ranked by Revenue
3.3 Global Acute Ischemic Stroke Diagnosis and Treatment Revenue by Companies
3.4 Top 3 and Top 5 Acute Ischemic Stroke Diagnosis and Treatment Companies in Global Market, by Revenue in 2020
3.5 Global Companies Acute Ischemic Stroke Diagnosis and Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Acute Ischemic Stroke Diagnosis and Treatment Players in Global Market
3.6.1 List of Global Tier 1 Acute Ischemic Stroke Diagnosis and Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Acute Ischemic Stroke Diagnosis and Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Acute Ischemic Stroke Diagnosis and Treatment Market Size Markets, 2021 & 2027
4.1.2 Computed Tomography (CT)
4.1.3 Magnetic Resonance Imaging (MRI)
4.1.4 Carotid Ultrasound
4.1.5 Cerebral Angiography
4.1.6 Electrocardiography
4.1.7 Echocardiography
4.1.8 Others
4.2 By Type - Global Acute Ischemic Stroke Diagnosis and Treatment Revenue & Forecasts
4.2.1 By Type - Global Acute Ischemic Stroke Diagnosis and Treatment Revenue, 2016-2021
4.2.2 By Type - Global Acute Ischemic Stroke Diagnosis and Treatment Revenue, 2022-2027
4.2.3 By Type - Global Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Acute Ischemic Stroke Diagnosis and Treatment Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Specialty Clinic
5.1.4 Others
5.2 By Application - Global Acute Ischemic Stroke Diagnosis and Treatment Revenue & Forecasts
5.2.1 By Application - Global Acute Ischemic Stroke Diagnosis and Treatment Revenue, 2016-2021
5.2.2 By Application - Global Acute Ischemic Stroke Diagnosis and Treatment Revenue, 2022-2027
5.2.3 By Application - Global Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Acute Ischemic Stroke Diagnosis and Treatment Market Size, 2021 & 2027
6.2 By Region - Global Acute Ischemic Stroke Diagnosis and Treatment Revenue & Forecasts
6.2.1 By Region - Global Acute Ischemic Stroke Diagnosis and Treatment Revenue, 2016-2021
6.2.2 By Region - Global Acute Ischemic Stroke Diagnosis and Treatment Revenue, 2022-2027
6.2.3 By Region - Global Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Acute Ischemic Stroke Diagnosis and Treatment Revenue, 2016-2027
6.3.2 US Acute Ischemic Stroke Diagnosis and Treatment Market Size, 2016-2027
6.3.3 Canada Acute Ischemic Stroke Diagnosis and Treatment Market Size, 2016-2027
6.3.4 Mexico Acute Ischemic Stroke Diagnosis and Treatment Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Acute Ischemic Stroke Diagnosis and Treatment Revenue, 2016-2027
6.4.2 Germany Acute Ischemic Stroke Diagnosis and Treatment Market Size, 2016-2027
6.4.3 France Acute Ischemic Stroke Diagnosis and Treatment Market Size, 2016-2027
6.4.4 U.K. Acute Ischemic Stroke Diagnosis and Treatment Market Size, 2016-2027
6.4.5 Italy Acute Ischemic Stroke Diagnosis and Treatment Market Size, 2016-2027
6.4.6 Russia Acute Ischemic Stroke Diagnosis and Treatment Market Size, 2016-2027
6.4.7 Nordic Countries Acute Ischemic Stroke Diagnosis and Treatment Market Size, 2016-2027
6.4.8 Benelux Acute Ischemic Stroke Diagnosis and Treatment Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Acute Ischemic Stroke Diagnosis and Treatment Revenue, 2016-2027
6.5.2 China Acute Ischemic Stroke Diagnosis and Treatment Market Size, 2016-2027
6.5.3 Japan Acute Ischemic Stroke Diagnosis and Treatment Market Size, 2016-2027
6.5.4 South Korea Acute Ischemic Stroke Diagnosis and Treatment Market Size, 2016-2027
6.5.5 Southeast Asia Acute Ischemic Stroke Diagnosis and Treatment Market Size, 2016-2027
6.5.6 India Acute Ischemic Stroke Diagnosis and Treatment Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Acute Ischemic Stroke Diagnosis and Treatment Revenue, 2016-2027
6.6.2 Brazil Acute Ischemic Stroke Diagnosis and Treatment Market Size, 2016-2027
6.6.3 Argentina Acute Ischemic Stroke Diagnosis and Treatment Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Acute Ischemic Stroke Diagnosis and Treatment Revenue, 2016-2027
6.7.2 Turkey Acute Ischemic Stroke Diagnosis and Treatment Market Size, 2016-2027
6.7.3 Israel Acute Ischemic Stroke Diagnosis and Treatment Market Size, 2016-2027
6.7.4 Saudi Arabia Acute Ischemic Stroke Diagnosis and Treatment Market Size, 2016-2027
6.7.5 UAE Acute Ischemic Stroke Diagnosis and Treatment Market Size, 2016-2027
7 Players Profiles
7.1 Abbott
7.1.1 Abbott Corporate Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Acute Ischemic Stroke Diagnosis and Treatment Major Product Offerings
7.1.4 Abbott Acute Ischemic Stroke Diagnosis and Treatment Revenue in Global (2016-2021)
7.1.5 Abbott Key News
7.2 Medtronic
7.2.1 Medtronic Corporate Summary
7.2.2 Medtronic Business Overview
7.2.3 Medtronic Acute Ischemic Stroke Diagnosis and Treatment Major Product Offerings
7.2.4 Medtronic Acute Ischemic Stroke Diagnosis and Treatment Revenue in Global (2016-2021)
7.2.5 Medtronic Key News
7.3 Boston Scientific
7.3.1 Boston Scientific Corporate Summary
7.3.2 Boston Scientific Business Overview
7.3.3 Boston Scientific Acute Ischemic Stroke Diagnosis and Treatment Major Product Offerings
7.3.4 Boston Scientific Acute Ischemic Stroke Diagnosis and Treatment Revenue in Global (2016-2021)
7.3.5 Boston Scientific Key News
7.4 Cordis
7.4.1 Cordis Corporate Summary
7.4.2 Cordis Business Overview
7.4.3 Cordis Acute Ischemic Stroke Diagnosis and Treatment Major Product Offerings
7.4.4 Cordis Acute Ischemic Stroke Diagnosis and Treatment Revenue in Global (2016-2021)
7.4.5 Cordis Key News
7.5 Philips
7.5.1 Philips Corporate Summary
7.5.2 Philips Business Overview
7.5.3 Philips Acute Ischemic Stroke Diagnosis and Treatment Major Product Offerings
7.5.4 Philips Acute Ischemic Stroke Diagnosis and Treatment Revenue in Global (2016-2021)
7.5.5 Philips Key News
7.6 GE Healthcare
7.6.1 GE Healthcare Corporate Summary
7.6.2 GE Healthcare Business Overview
7.6.3 GE Healthcare Acute Ischemic Stroke Diagnosis and Treatment Major Product Offerings
7.6.4 GE Healthcare Acute Ischemic Stroke Diagnosis and Treatment Revenue in Global (2016-2021)
7.6.5 GE Healthcare Key News
7.7 Siemens
7.7.1 Siemens Corporate Summary
7.7.2 Siemens Business Overview
7.7.3 Siemens Acute Ischemic Stroke Diagnosis and Treatment Major Product Offerings
7.4.4 Siemens Acute Ischemic Stroke Diagnosis and Treatment Revenue in Global (2016-2021)
7.7.5 Siemens Key News
7.8 Stryker
7.8.1 Stryker Corporate Summary
7.8.2 Stryker Business Overview
7.8.3 Stryker Acute Ischemic Stroke Diagnosis and Treatment Major Product Offerings
7.8.4 Stryker Acute Ischemic Stroke Diagnosis and Treatment Revenue in Global (2016-2021)
7.8.5 Stryker Key News
7.9 Genentech
7.9.1 Genentech Corporate Summary
7.9.2 Genentech Business Overview
7.9.3 Genentech Acute Ischemic Stroke Diagnosis and Treatment Major Product Offerings
7.9.4 Genentech Acute Ischemic Stroke Diagnosis and Treatment Revenue in Global (2016-2021)
7.9.5 Genentech Key News
7.10 Merck
7.10.1 Merck Corporate Summary
7.10.2 Merck Business Overview
7.10.3 Merck Acute Ischemic Stroke Diagnosis and Treatment Major Product Offerings
7.10.4 Merck Acute Ischemic Stroke Diagnosis and Treatment Revenue in Global (2016-2021)
7.10.5 Merck Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Acute Ischemic Stroke Diagnosis and Treatment Market Opportunities & Trends in Global Market
Table 2. Acute Ischemic Stroke Diagnosis and Treatment Market Drivers in Global Market
Table 3. Acute Ischemic Stroke Diagnosis and Treatment Market Restraints in Global Market
Table 4. Key Players of Acute Ischemic Stroke Diagnosis and Treatment in Global Market
Table 5. Top Acute Ischemic Stroke Diagnosis and Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Acute Ischemic Stroke Diagnosis and Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Acute Ischemic Stroke Diagnosis and Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies Acute Ischemic Stroke Diagnosis and Treatment Product Type
Table 9. List of Global Tier 1 Acute Ischemic Stroke Diagnosis and Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Acute Ischemic Stroke Diagnosis and Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type